{"id":"NCT01838681","sponsor":"H. Lundbeck A/S","briefTitle":"Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment","officialTitle":"Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose Long-term Study to Evaluate the Maintenance of Efficacy and Safety of 1 to 3 mg/Day of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-06","primaryCompletion":"2016-06","completion":"2016-06","firstPosted":"2013-04-24","resultsPosted":"2017-08-09","lastUpdate":"2017-08-09"},"enrollment":1986,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Major Depressive Disorder"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Brexpiprazole","otherNames":[]},{"type":"DRUG","name":"ADT","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Brexpiprazole","type":"EXPERIMENTAL"}],"summary":"To evaluate the long-term efficacy and safety of brexpiprazole as an adjunctive treatment to an antidepressant treatment (ADT) for adult patients with Major Depressive Disorder (MDD).","primaryOutcome":{"measure":"Full Remission During the Randomised Treatment Period","timeFrame":"From randomisation to end of Period B (24 weeks)","effectByArm":[{"arm":"Period B Placebo and ADT (24 Weeks Randomised Treatment)","deltaMin":110,"sd":null},{"arm":"Period B Brexpiprazole and ADT (24 Weeks Randomised Treatment)","deltaMin":95,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.2641"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":10},"locations":{"siteCount":107,"countries":["United States","Bulgaria","Canada","Estonia","Finland","Germany","Latvia","Lithuania","Mexico","Poland","Romania","Russia","South Korea","Sweden","Ukraine","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":13,"n":441},"commonTop":["Headache","Weight increased","Nasopharyngitis","Accidental overdose"]}}